Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation

Published:2015-05 Issue:5 Volume:15 Page:298-302
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Antar Ahmad,Kharfan-Dabaja Mohamed A.,Mahfouz Rami,Bazarbachi Ali

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. The roles of FLT3 in hematopoiesis and leukemia;Gilliland;Blood,2002

2. FLT3: ITDoes matter in leukemia;Levis;Leukemia,2003

3. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

4. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm;Frohling;Blood,2002

5. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis;Thiede;Blood,2002

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions;Biomedicines;2024-04-29

2. Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study;Clinical Cancer Research;2024-03-22

3. Matrine regulates miR‐495‐3p/miR‐543/PDK1 axis to repress the progression of acute myeloid leukemia via the Wnt/β‐catenin pathway;Chemical Biology & Drug Design;2024-01

4. Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study;Signal Transduction and Targeted Therapy;2023-09-14

5. Recent advances in allogeneic transplantation for acute myeloid leukemia;Current Opinion in Oncology;2023-08-30